Evidence map›Paper›PMID 40073152›Full record

ArticleScience translational medicine2025

The pentameric complex is not required for congenital CMV transmission in seronegative rhesus macaques.

Hsuan-Yuan Wang, Husam Taher, Craig N Kreklywich, Kimberli A Schmidt, Elizabeth A Scheef, Richard Barfield, Claire E Otero, Sarah M Valencia, Ke Zhang, Claire Callahan and 23 more

Abstract read
In one paragraph

Article in Science translational medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

33 authors.

Hsuan-Yuan WangDepartment of Pediatrics, Weill Cornell Medicine, New York, NY 10065, USA.ORCID 0000-0001-9248-4281
Husam TaherVaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR 97006, USA.
Craig N KreklywichVaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR 97006, USA.
Kimberli A SchmidtDepartment of Pathology and Laboratory Medicine, Center for Immunology and Infectious Diseases, California National Primate Research Center, University of California Davis, Davis, CA 95616, USA.ORCID 0000-0003-4927-6991
Elizabeth A ScheefDivision of Immunology, Tulane National Primate Research Center, Covington, LA 70433, USA.ORCID 0000-0002-4209-0409
Richard BarfieldDepartment of Biostatistics and Bioinformatics and Center for Human Systems Immunology, Duke University School of Medicine, Durham, NC 27710, USA.
Claire E OteroDepartment of Pediatrics, Weill Cornell Medicine, New York, NY 10065, USA.ORCID 0000-0001-7127-2327
Sarah M ValenciaDuke University Medical Center, Durham, NC 27710, USA.ORCID 0000-0002-8878-8407
Ke ZhangCutaneous Biology Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.ORCID 0000-0002-6153-6912
Claire CallahanCutaneous Biology Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.ORCID 0009-0002-9138-4689
Francesco MonticoloCutaneous Biology Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
Yueqing QiaoCutaneous Biology Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
Roxanne M GilbrideVaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR 97006, USA.ORCID 0000-0001-6040-104X
Chelsea M CrooksDepartment of Pediatrics, Weill Cornell Medicine, New York, NY 10065, USA.ORCID 0000-0003-3874-4577
Anne MirzaDepartment of Microbiology, University of Massachusetts Chan Medical School, Worcester, MA 01655, USA.
Kelsey KnightInfectious Disease and Immunology, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA 01655, USA.
Matilda J MoströmDivision of Immunology, Tulane National Primate Research Center, Covington, LA 70433, USA.ORCID 0000-0001-7261-6638
Tabitha D ManuelDivision of Immunology, Tulane National Primate Research Center, Covington, LA 70433, USA.ORCID 0009-0001-9212-6094
Lesli SpreheDivision of Immunology, Tulane National Primate Research Center, Covington, LA 70433, USA.
Savannah KendallDivision of Immunology, Tulane National Primate Research Center, Covington, LA 70433, USA.
Nathan Vande BurgtVaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR 97006, USA.ORCID 0000-0001-6311-9082
Timothy F KowalikDepartment of Microbiology, University of Massachusetts Chan Medical School, Worcester, MA 01655, USA.ORCID 0000-0001-6096-3018
Peter A BarryDepartment of Pathology and Laboratory Medicine, Center for Immunology and Infectious Diseases, California National Primate Research Center, University of California Davis, Davis, CA 95616, USA.
Scott G HansenVaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR 97006, USA.ORCID 0000-0002-9845-6481
Jian ShuCutaneous Biology Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
Alice F TarantalDepartments of Pediatrics and Cell Biology and Human Anatomy, School of Medicine, and California National Primate Research Center, University of California Davis, Davis, CA 95616, USA.
Cliburn ChanDepartment of Biostatistics and Bioinformatics and Center for Human Systems Immunology, Duke University School of Medicine, Durham, NC 27710, USA.ORCID 0000-0001-5901-6806
Daniel N StreblowVaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR 97006, USA.
Louis J PickerVaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR 97006, USA.ORCID 0000-0003-0546-398X
Amitinder KaurDivision of Immunology, Tulane National Primate Research Center, Covington, LA 70433, USA.ORCID 0000-0001-6609-4896
Klaus FrühVaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR 97006, USA.ORCID 0000-0001-8014-3877
Sallie R PermarDepartment of Pediatrics, Weill Cornell Medicine, New York, NY 10065, USA.ORCID 0000-0003-1438-4554
Daniel MalouliVaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR 97006, USA.ORCID 0000-0003-1287-7283

Funding

Upgrade of confocal microscopy at the Oregon National Primate Research CenterP51OD011092 · OD · OREGON HEALTH & SCIENCE UNIVERSITY · PI Bonnie J. Nagel · 2012 to 2026
$203.9M
National Institute on Aging (NIA) ColonyP51OD011107 · OD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Simon J. Atkinson · 2012 to 2026
$191.5M
Tulane NPRC SPF Sheltered Outdoor Enclosure ExpansionP51OD011104 · OD · TULANE UNIVERSITY OF LOUISIANA · PI L Lee HAMM · 2012 to 2026
$142.4M
Support for QA/QC for Prior Approval ProcessUL1TR002553 · NCATS · DUKE UNIVERSITY · PI LI, JENNIFER S, MCNAMARA, JAMES O. · 2018 to 2023
$58.5M
Virology CoreP01AI129859 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI Sallie R. Permar · 2019 to 2026
$31.0M
Phase 2 Enhancement of Outdoor Group Housing for U42 SPF 9 Rhesus MacaquesU42OD023038 · OD · OREGON HEALTH & SCIENCE UNIVERSITY · PI Andrew Haertel · 2016 to 2026
$21.9M
Virology and Vector Production Core CU19AI128741 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI NELSON, JAY A · 2017 to 2021
$11.8M
Evasion of Antigen Presentation by Rhesus CytomegalovirusR01AI059457 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI FRUH, KLAUS J · 2005 to 2021
$6.2M
Viral Testing CoreU42OD010426 · OD · OREGON HEALTH & SCIENCE UNIVERSITY · PI Andrew Haertel, Lauren Drew Martin · 2013 to 2026
$6.0M
Non-canonical epitope presentation and antigen processing by MHC-ER01AI175459 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI Klaus J Fruh, Jonah B. Sacha · 2023 to 2026
$2.8M
Ultrasound Imaging for Nonhuman Primate Translational ResearchS10OD016261 · OD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI TARANTAL, ALICE F · 2013 to 2013
$203k
NCATS NIH HHS UL1 TR002553NIAID NIH HHS P01 AI129859NIAID NIH HHS R01 AI059457NIAID NIH HHS R01 AI175459NIAID NIH HHS U19 AI128741NIH HHS P51 OD011092NIH HHS P51 OD011104NIH HHS P51 OD011107NIH HHS S10 OD016261NIH HHS U42 OD010426NIH HHS U42 OD023038
6 · The paper itself

Abstract

Congenital cytomegalovirus (cCMV) is the leading infectious cause of neonatal neurological impairment worldwide, but the viral factors enabling vertical spread across the placenta remain undetermined. The pentameric complex (PC), composed of the subunits gH/gL/UL128/UL130/UL131A, has been demonstrated to be important for entry into nonfibroblast cells in vitro. These findings link the PC to broad cell tropism and virus dissemination in vivo, denoting all subunits as potential targets for intervention strategies and vaccine development. To determine the relevance of the PC for congenital transmission in a translational nonhuman primate model, we engineered a rhesus CMV (RhCMV) mutant lacking the orthologs of UL128 and UL130, which demonstrated diminished infection of epithelial cells in vitro. However, intravenous inoculation of either CD4

Indexed as

CytomegalovirusCytomegalovirus InfectionsInfectious Disease Transmission, VerticalMacaca mulattaAnimalsFemaleHumansPregnancy

Identifiers

PMID40073152
PMCPMC12208562

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.